As the GFR loss aggravates, the disturbed mineral metabolism worsens the bone
microstructure and remodelling‐scenario, which is known as CKD‐mineral bone disease …

There is increasing evidence for the involvement of the skeleton in the regulation of
atherosclerotic vascular disease. Osteocalcin, an osteoblast derived protein, exists in two …

Medial vascular calcification, associated with enhanced mortality in chronic kidney disease
(CKD), is fostered by osteo-/chondrogenic transdifferentiation of vascular smooth muscle …

Background: In pseudoxanthoma elasticum (PXE), low pyrophosphate levels may cause
ectopic mineralization, leading to skin changes, visual impairment, and peripheral arterial …

Vascular calcification increases the risk of cardiovascular disease and death in patients with
chronic kidney disease (CKD). Increased activity of mammalian target of rapamycin complex …

Abstract Background/Aims: This cross-sectional study was designed to assess the
relationship between vascular stiffness (VS) and bone-related proteins involved in the …

Vascular calcification (VC) occurs in patients with chronic kidney disease (CKD) and
contributes to cardiovascular dysfunction and mortality. Parathyroid hormone (PTH) is a …

Background Vascular calcifications are associated with a three-to fourfold increased risk of
cardiovascular disease (CVD) and are highly prevalent in type 2 diabetes patients …

For many decades, cardiovascular calcification has been considered as a passive process,
accompanying atheroma progression, correlated with plaque burden, and apparently …

Vascular calcification is a main cause of increased cardiovascular morbidity and mortality in
chronic kidney disease (CKD) patients. This study aimed to investigate the role of the bone …